Fig. 3
From: Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
Low expression of BCL2L13 significantly affects the prognosis of ccRCC and pRCC. A–B Kaplan–Meier survival plot of ccRCC (A) and pRCC (B) that grouped by BCL2L13 mRNA levels. C Poor prognosis of ccRCC that related to the down-regulation of BCL2L13 is independent of patients’ gender (left) or tumor grade (right). Log-rank test was implemented for comparison of survival probability